vs
CLOVER HEALTH INVESTMENTS, CORP.（CLOV）与UiPath, Inc.（PATH）财务数据对比。点击上方公司名可切换其他公司
CLOVER HEALTH INVESTMENTS, CORP.的季度营收约是UiPath, Inc.的1.2倍（$487.7M vs $411.1M），UiPath, Inc.净利率更高（48.4% vs -10.1%，领先58.5%），CLOVER HEALTH INVESTMENTS, CORP.同比增速更快（44.7% vs 15.9%），UiPath, Inc.自由现金流更多（$25.1M vs $-69.0M），过去两年CLOVER HEALTH INVESTMENTS, CORP.的营收复合增速更高（18.6% vs 0.7%）
克利弗健康投资公司是2014年成立的美国医疗保健企业，主营联邦医疗保险优势计划保险产品，是与美国政府直接签约合作的机构。目前公司为美国11个州的联邦医疗保险参保人提供健康管理服务，并已于2021年1月8日公开上市。
UiPath是一家全球化软件企业，专注于开发人工智能、智能自动化及流程编排类软件，其产品支持用户搭建与调度AI代理，实现复杂业务流程、工作流的自动化运行，助力各行业客户提升运营效率、降低人力成本。
CLOV vs PATH — 直观对比
营收规模更大
CLOV
是对方的1.2倍
$411.1M
营收增速更快
CLOV
高出28.8%
15.9%
净利率更高
PATH
高出58.5%
-10.1%
自由现金流更多
PATH
多$94.1M
$-69.0M
两年增速更快
CLOV
近两年复合增速
0.7%
损益表 — Q4 FY2025 vs Q3 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $487.7M | $411.1M |
| 净利润 | $-49.3M | $198.8M |
| 毛利率 | — | 83.3% |
| 营业利润率 | -10.1% | 3.2% |
| 净利率 | -10.1% | 48.4% |
| 营收同比 | 44.7% | 15.9% |
| 净利润同比 | -123.2% | 1966.2% |
| 每股收益（稀释后） | — | $0.37 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收CLOVPATH
| Q4 25 | $487.7M | $411.1M | ||
| Q3 25 | $496.6M | $361.7M | ||
| Q2 25 | $477.6M | $356.6M | ||
| Q1 25 | $462.3M | $423.6M | ||
| Q4 24 | $337.0M | $354.7M | ||
| Q3 24 | $331.0M | $316.3M | ||
| Q2 24 | $356.3M | $335.1M | ||
| Q1 24 | $346.9M | $405.3M |
净利润CLOVPATH
| Q4 25 | $-49.3M | $198.8M | ||
| Q3 25 | $-24.4M | $1.6M | ||
| Q2 25 | $-10.6M | $-22.6M | ||
| Q1 25 | $-1.3M | $51.8M | ||
| Q4 24 | $-22.1M | $-10.7M | ||
| Q3 24 | $-9.2M | $-86.1M | ||
| Q2 24 | $7.4M | $-28.7M | ||
| Q1 24 | $-19.2M | $33.9M |
毛利率CLOVPATH
| Q4 25 | — | 83.3% | ||
| Q3 25 | — | 82.2% | ||
| Q2 25 | — | 82.1% | ||
| Q1 25 | — | 84.8% | ||
| Q4 24 | — | 82.0% | ||
| Q3 24 | 24.5% | 80.0% | ||
| Q2 24 | 30.3% | 83.5% | ||
| Q1 24 | 23.6% | 86.8% |
营业利润率CLOVPATH
| Q4 25 | -10.1% | 3.2% | ||
| Q3 25 | -4.9% | -5.6% | ||
| Q2 25 | -2.2% | -4.6% | ||
| Q1 25 | -0.3% | 7.9% | ||
| Q4 24 | -6.4% | -12.2% | ||
| Q3 24 | -2.7% | -32.7% | ||
| Q2 24 | 2.0% | -14.8% | ||
| Q1 24 | -6.5% | 3.7% |
净利率CLOVPATH
| Q4 25 | -10.1% | 48.4% | ||
| Q3 25 | -4.9% | 0.4% | ||
| Q2 25 | -2.2% | -6.3% | ||
| Q1 25 | -0.3% | 12.2% | ||
| Q4 24 | -6.6% | -3.0% | ||
| Q3 24 | -2.8% | -27.2% | ||
| Q2 24 | 2.1% | -8.6% | ||
| Q1 24 | -5.5% | 8.4% |
每股收益（稀释后）CLOVPATH
| Q4 25 | — | $0.37 | ||
| Q3 25 | — | $0.00 | ||
| Q2 25 | — | $-0.04 | ||
| Q1 25 | — | $0.09 | ||
| Q4 24 | — | $-0.02 | ||
| Q3 24 | — | $-0.15 | ||
| Q2 24 | — | $-0.05 | ||
| Q1 24 | — | $0.07 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $78.3M | $1.4B |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $308.7M | $1.9B |
| 总资产 | $541.0M | $2.9B |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资CLOVPATH
| Q4 25 | $78.3M | $1.4B | ||
| Q3 25 | — | $1.4B | ||
| Q2 25 | — | $1.6B | ||
| Q1 25 | — | $1.6B | ||
| Q4 24 | $194.5M | $1.6B | ||
| Q3 24 | $288.0M | $1.7B | ||
| Q2 24 | $254.8M | $1.9B | ||
| Q1 24 | $208.3M | $1.9B |
股东权益CLOVPATH
| Q4 25 | $308.7M | $1.9B | ||
| Q3 25 | $340.9M | $1.7B | ||
| Q2 25 | $344.2M | $1.7B | ||
| Q1 25 | $336.1M | $1.8B | ||
| Q4 24 | $341.1M | $1.7B | ||
| Q3 24 | $342.2M | $1.8B | ||
| Q2 24 | $324.9M | $2.0B | ||
| Q1 24 | $292.5M | $2.0B |
总资产CLOVPATH
| Q4 25 | $541.0M | $2.9B | ||
| Q3 25 | $559.7M | $2.6B | ||
| Q2 25 | $575.0M | $2.6B | ||
| Q1 25 | $583.7M | $2.9B | ||
| Q4 24 | $580.7M | $2.7B | ||
| Q3 24 | $653.0M | $2.7B | ||
| Q2 24 | $674.2M | $2.8B | ||
| Q1 24 | $671.8M | $3.0B |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-66.9M | $28.3M |
| 自由现金流经营现金流 - 资本支出 | $-69.0M | $25.1M |
| 自由现金流率自由现金流/营收 | -14.1% | 6.1% |
| 资本支出强度资本支出/营收 | 0.4% | 0.8% |
| 现金转化率经营现金流/净利润 | — | 0.14× |
| 过去12个月自由现金流最近4个季度 | $-69.2M | — |
8季度趋势，按日历期对齐
经营现金流CLOVPATH
| Q4 25 | $-66.9M | $28.3M | ||
| Q3 25 | $12.1M | $41.6M | ||
| Q2 25 | $5.4M | $119.0M | ||
| Q1 25 | $-16.3M | $146.1M | ||
| Q4 24 | $34.8M | $28.1M | ||
| Q3 24 | $50.0M | $46.4M | ||
| Q2 24 | $44.8M | $100.0M | ||
| Q1 24 | $25.9M | $145.6M |
自由现金流CLOVPATH
| Q4 25 | $-69.0M | $25.1M | ||
| Q3 25 | $11.4M | — | ||
| Q2 25 | $4.8M | $106.2M | ||
| Q1 25 | $-16.5M | $138.7M | ||
| Q4 24 | $33.3M | $23.2M | ||
| Q3 24 | $49.6M | $45.0M | ||
| Q2 24 | $44.4M | $98.8M | ||
| Q1 24 | $25.5M | $141.8M |
自由现金流率CLOVPATH
| Q4 25 | -14.1% | 6.1% | ||
| Q3 25 | 2.3% | — | ||
| Q2 25 | 1.0% | 29.8% | ||
| Q1 25 | -3.6% | 32.7% | ||
| Q4 24 | 9.9% | 6.5% | ||
| Q3 24 | 15.0% | 14.2% | ||
| Q2 24 | 12.5% | 29.5% | ||
| Q1 24 | 7.3% | 35.0% |
资本支出强度CLOVPATH
| Q4 25 | 0.4% | 0.8% | ||
| Q3 25 | 0.1% | 0.0% | ||
| Q2 25 | 0.1% | 3.6% | ||
| Q1 25 | 0.0% | 1.7% | ||
| Q4 24 | 0.5% | 1.4% | ||
| Q3 24 | 0.1% | 0.4% | ||
| Q2 24 | 0.1% | 0.4% | ||
| Q1 24 | 0.1% | 0.9% |
现金转化率CLOVPATH
| Q4 25 | — | 0.14× | ||
| Q3 25 | — | 26.25× | ||
| Q2 25 | — | — | ||
| Q1 25 | — | 2.82× | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | 6.04× | — | ||
| Q1 24 | — | 4.29× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
CLOV
暂无分部数据
PATH
| Subscription Services | $247.6M | 60% |
| License | $150.0M | 36% |
| Professional Services And Other | $13.5M | 3% |
